Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care. JCO global oncology Blayney, D. W., Bariani, G., Das, D., Dawood, S., Gnant, M., De Guzman, R., Martin, S. E., O'Mahony, D., Roach, A., Ruff, P., Sampaio, C., Sanchez, J. A., Vanderpuye, V., Kamal, A., Hendricks, C. 2021; 7: 1513-1521

Abstract

This report from ASCO's International Quality Steering Group summarizes early learnings on how the COVID-19 pandemic and its stresses have disproportionately affected cancer care delivery and its delivery systems across the world. This article shares perspectives from eight different countries, including Austria, Brazil, Ghana, Honduras, Ireland, the Philippines, South Africa, and the United Arab Emirates, which provide insight to their unique issues, challenges, and barriers to quality improvement in cancer care during the pandemic. These perspectives shed light on some key recommendations applicable on a global scale and focus on access to care, importance of expanding and developing new treatments for both COVID-19 and cancer, access to telemedicine, collecting and using COVID-19 and cancer registry data, establishing measures and guidelines to further enhance quality of care, and expanding communication among governments, health care systems, and health care providers. The impact of the COVID-19 pandemic on cancer care and quality improvement has been and will continue to be felt across the globe, but this report aims to share these experiences and learnings and to assist ASCO's international members and our global fight against the pandemic and cancer.

View details for DOI 10.1200/GO.21.00281

View details for PubMedID 34714666